For example: Apple Inc, UTIL, Aluminum
Anavex Life Sciences Corp
NASDAQ:AVXL
Market Close 11/27
5.37 USD +0.17 (+3.27%)
OPEN:
5.19
DAY RANGE:
5.18 - 5.40
PE:
-5.62
PB:
6.05
PS:
0.00
WTD % 3.87
MTD % -8.98
QTD % 18.02
YTD % 107.34
* Updated at market close
Anavex Life Sciences Corp (NASDAQ:AVXL) opened on Nov 27, 2020 at 5.19 USD and scaled up by 3.27%. The intraday price range was 5.18 - 5.40 USD and eventually ended the session at 5.37 USD. The stock trade volume was 552,000.00 shares. The company's 52-week range is 2.20 - 7.69 USD.
Trading Statistics (Market Close Nov 27, 2020)
Market Cap 315.03 M
Outstanding Stock 45.43 M
Dividend 0.00
Dividend Yield 0.00
EPS -0.60
YTD Change 107.34%
52 Week's Range 2.20 - 7.69
Key Ratio & Margins (Market Close Nov 27, 2020)
Price/Earning -5.62
Price/Book Value 6.05
Price/Sales 0.00
ROA -
ROE -
Debt/Equity 0.25
Company Self Description
Anavex Life Sciences Corp a clinical-stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system diseases. The company's lead drug candidate is ANAVEX 2-73, which has completed Phase 2a clinical trial for Alzheimer's disease; and preclinical clinical trials to treat Parkinson's disease. It was founded in 2006 and is headquartered in New York, New York, United States.
Business Information
Anavex Life Sciences Corp
Sector Health Care
Industry Biotechnology
Exchange NASDAQ
Top Competitors (Market Close Nov 27, 2020)
  AVXL BFRA SURF VYGR
Daily Change (%) 3.27 -0.42 1.42 0.95
WTD (%) 3.87 -0.83 -1.01 1.56
MTD (%) -8.98 12.91 -6.21 -20.41
QTD (%) 18.02 -8.43 13.91 -20.71
YTD (%) 107.34 -30.66 318.09 -39.35
52-Week Change (%) 127.54 -20.33 291.04 -38.76
Stock Performance (Market Close Nov 27, 2020)
  AVXL BFRA SURF VYGR
Daily Change (%) 3.27 -0.42 1.42 0.95
WTD (%) 3.87 -0.83 -1.01 1.56
MTD (%) -8.98 12.91 -6.21 -20.41
QTD (%) 18.02 -8.43 13.91 -20.71
YTD (%) 107.34 -30.66 318.09 -39.35
52-Week Change (%) 127.54 -20.33 291.04 -38.76
Key Fundamentals (Market Close Nov 27, 2020)
  AVXL BFRA SURF VYGR
Market Cap 315.03 M 320.02 M 313.66 M 316.67 M
Revenue Growth - - - -
Net Income Growth - - - -
Profit Margin 0.00 0.00 -168.40% -106.20%
P/E Ratio -5.62 0 -1.73 -14.87
Price to Sales Ratio 0.00 0 3.01 17.99
Price to Book Ratio 6.05 13.78 1.14 6.59
Enterprise Value to EBITDA -5.65 0 -14.21 -3.06
ROA - 0 -25.60% -20.00%
ROE - 0 -44.60% -71.10%
Debt/Equity 0.25 1.39 0.69 2.81
Asset Turnover Ratio 0.00 0 0.15 0.19
Current Ratio 6.24 3.55 6.06 5.13
Dividend Yield 0.00 - 0 0
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Revenue 0.00 0.00 0.00 0.00
Cost Of Revenue 0.00 0.00 0.00 0.00
Gross Profit 0.00 0.00 0.00 0.00
Selling General & Administrative Expenses 5.99 M 5.01 M 8.33 M 4.84 M
Research & Development 13.34 M 10.67 M 7.25 M 2.27 M
Operating Income -19.33 M -15.68 M -15.59 M -7.11 M
Net Income -17.45 M -13.46 M -14.74 M -12.11 M
EPS -0.39 -0.33 -0.42 -0.65
Diluted EPS -0.39 -0.33 -0.42 -0.65
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Revenue 0.00 0.00 0.00 0.00
Cost Of Revenue 0.00 0.00 0.00 0.00
Gross Profit 0.00 0.00 0.00 0.00
Selling General & Administrative Expenses 1.39 M 2.06 M 1.76 M 1.48 M
Research & Development 5.76 M 6.08 M 5.71 M 4.41 M
Operating Income -7.15 M -8.14 M -7.47 M -5.89 M
Net Income -7.07 M -8.01 M -7.33 M -5.79 M
EPS -0.14 -0.17 -0.16 -0.13
Diluted EPS -0.14 -0.17 -0.16 -0.13
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Total Current Assets 24.22 M 27.79 M 9.45 M 15.47 M
Cash & Cash Equivalents 22.98 M 27.49 M 9.24 M 15.29 M
Total Assets 24.38 M 27.84 M 9.50 M 15.47 M
Total Current Liabilities 3.88 M 3.58 M 3.19 M 2.66 M
Total Liabilities 3.88 M 3.58 M 3.19 M 2.66 M
Shareholder's Equity 20.49 M 24.25 M 6.31 M 12.81 M
Outstanding Stock 45.43 M 42.17 M 35.71 M 30.11 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Total Current Assets 21.82 M 20.55 M 22.10 M 24.22 M
Cash & Cash Equivalents 21.25 M 19.46 M 20.72 M 22.98 M
Total Assets 21.97 M 20.55 M 22.10 M 24.38 M
Total Current Liabilities 4.34 M 6.37 M 4.88 M 3.88 M
Total Liabilities 4.34 M 6.37 M 4.88 M 3.88 M
Shareholder's Equity 17.63 M 14.18 M 17.22 M 20.49 M
Outstanding Stock 49.12 M 46.89 M 46.59 M 45.43 M
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net Cash Flow from Operations -12.58 M -9.02 M -9.24 M -4.23 M
Capital Expenditures 0.00 0.00 0.00 0.00
Net Cash Flow from Investing Activities 0.00 0.00 0.00 0.00
Net Cash Flow from Financial Activities 8.07 M 27.27 M 3.13 M 12.26 M
Free Cash Flow -12.58 M -9.02 M -9.24 M -4.23 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Net Cash Flow from Operations -7.50 M -9.02 M -9.24 M -4.23 M
Capital Expenditures 0.00 0.00 0.00 0.00
Net Cash Flow from Investing Activities 0.00 0.00 0.00 0.00
Net Cash Flow from Financial Activities 9.29 M 3.07 M 1.94 M 1.16 M
Free Cash Flow -7.50 M -4.33 M -4.16 M -4.05 M
Key Ratios (Market Close Nov 27, 2020)
Valuation Ratios 2020 2019 2018 2017
P/E Ratio -5.62 -5.87 -3.39 -7.00
Price to Sales Ratio 0.00 0.00 0.00 0.00
Price to Book Ratio 6.05 7.20 20.55 13.26
Enterprise Value to EBIT -6.00 -11.00 -8.00 -13.00
Enterprise Value to EBITDA -5.65 -11.17 -8.16 -13.46
Profitability Ratios 2020 2019 2018 2017
Revenue Growth - - - -
Net Income Growth - - - -
ROA - - -83.60% -54.90%
ROE - - -99.00% -60.70%
Liquidity Ratios 2020 2019 2018 2017
Working Capital 20.34 M 24.20 M 6.26 M 12.81 M
Current Ratio 6.24 7.75 2.96 5.81
Efficiency & Capital Structure Ratios 2020 2019 2018 2017
Debt Equity Ratio 0.25 0.15 0.51 0.21
Asset Turnover Ratio - - 0.00 0.00
Scratchpad (max of 30 tickers)
Symbol Last Price Change
Empty Scratchpad
Portfolio (max of 30 tickers)
Login is required to view your portfolio.